CYTX News Alert Cytori Therapeutics Inc (CYTX) 0.48 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cytori Therapeutics Inc (CYTX) 0.48 $CYTX

Cytori and BARDA amend contract for development of thermal burn cell therapy
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 6:45AM CST

CYTX: 0.48 (-0.01)

Cytori and BARDA Amend Contract Option to Accelerate the Advancement of a Thermal Burn Injury Countermeasure
Business Wire - Fri Dec 19, 7:00AM CST
Cytori Therapeutics (NASDAQ: CYTX) today announced that the Company and Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, executed an amendment of a contract option originally signed in August 2014 to fund continued investigation and development of Cytori Cell Therapy(TM) for use in thermal burn injuries.
CYTX: 0.48 (-0.01)

Cytori to Host an Informational Session on Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna
Business Wire - Thu Dec 18, 4:39PM CST
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announces it will be hosting an information session dedicated to its planned STAR pivotal trial and scleroderma, featuring principal investigator Dr. Dinesh Khanna. The session will be held on January 14, 2015, from 1:30 PM to 4:30 PM at the Prescott Hotel, 545 Post Street, San Francisco, Room 736.
CYTX: 0.48 (-0.01)

Stock to Watch: Cytori Therapeutics Up 5.7% (CYTX)
Comtex SmarTrend(R) - Thu Dec 18, 12:48PM CST
Cytori Therapeutics (NASDAQ:CYTX) is one of today's best performing penny stocks, up 5.7% to $0.52 on 1.0x average daily volume. Thus far today, Cytori Therapeutics has traded 1.6 million shares, vs. average volume of 1.5 million shares per day. The stock has outperformed the Dow (5.7% to the Dow's 1.7%) and outperformed the S&P 500 (5.7% to the S&P's 1.8%) during today's trading.
CYTX: 0.48 (-0.01)

Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
PR Newswire - Thu Dec 18, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Geron Corporation (NASDAQ: GERN), PDL BioPharma Inc. (NASDAQ: PDLI), Cytori Therapeutics Inc. (NASDAQ: CYTX), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 17, 2014, surged as the Dow Jones Industrial Average finished at 17,356.87, up 1.69% and the NASDAQ Composite closed at 4,644.31, up 2.12%. The S&P 500 finished the session 2.04% higher at 2,012.89. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Index ended the day at 791.66, up 1.90%, with the index advancing 6.28% in the previous three months. Register for your complimentary reports on these five stocks at:
NAVB: 2.00 (+0.02), CYTX: 0.48 (-0.01), GERN: 3.06 (+0.05), ARIA: 6.81 (+0.15), PDLI: 7.61 (unch)

Global Regenerative Medicine Market: 20.16% CAGR to 2019 Forecasts a New Research Report at ReportsnReports.com
PRWeb - Wed Dec 17, 10:30PM CST
The rise in prevalence of degenerative diseases is one of the main factors which is driving the growth of the global regenerative medicine market. Regenerative medicine is involved in the process of replacing or regenerating human tissues, cells and/or organs for normal functioning of the body. Small molecules and biologics, gene therapy, and cell therapy are the three main technologies which are used in regenerative medicine. The global market is expected to grow at a compound annual growth rate of 20.16% during the period from 2014 to 2019. Increase in demand for regenerative products and an increase in research and development are also fueling the growth in the global regenerative medicine market.
RTIX: 5.20 (unch), MDT: 74.08 (+0.31), PSTI: 2.46 (unch), OSIR: 14.87 (+0.13), OPXA: 0.80 (+0.01), FCSC: 2.38 (+0.04), BAX: 74.45 (-0.04), CYTX: 0.48 (-0.01)

Cytori to Provide Corporate Update at 2015 Biotech Showcase(TM) in San Francisco
Business Wire - Wed Dec 17, 6:25PM CST
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that the company has been selected to present at the Biotech Showcase(TM) at 3:30 PM Pacific Time (6:30 PM Eastern Time) on Monday, January 12, 2015. The presentation will take place in the C-Mission II room at the Parc 55 Wyndham Hotel in San Francisco.
CYTX: 0.48 (-0.01)

Cytori Therapeutics Up 6.2%, Penny Stock Attracts Attention (CYTX)
Comtex SmarTrend(R) - Wed Dec 10, 10:05AM CST
Cytori Therapeutics (NASDAQ:CYTX) is one of today's best performing penny stocks, up 6.2% to $0.49 on 2.1x average daily volume. Thus far today, Cytori Therapeutics has traded 3.0 million shares, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (7.3% to the Dow's -0.6%) and outperformed the S&P 500 (7.3% to the S&P's -0.5%) during today's trading.
CYTX: 0.48 (-0.01)

FDA Grants Cytori Conditional Approval for a U.S. Pivotal Clinical Trial in Scleroderma
Business Wire - Wed Dec 10, 7:01AM CST
Cytori Therapeutics, Inc. (NASDAQ:CYTX) today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval for an Investigational Device Exemption (IDE) for a pivotal clinical trial, named the 'STAR' trial, to evaluate Cytori Cell Therapy(TM) as a potential treatment for impaired hand function in scleroderma, a rare autoimmune disease affecting approximately 50,000 patients in the United States.
CYTX: 0.48 (-0.01)

Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing
CNW Group - Fri Dec 05, 7:00AM CST
Cytori Therapeutics (NASDAQ: CYTX), today announced that the presentation and corporate update given on December 4 by President and CEO Marc Hedrick, M.D. is now available for on-demand viewing at VirtualInvestorConferences.com.
CYTX: 0.48 (-0.01)

Cytori says new Japanese regen laws should goose Celution sales
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 12:14PM CST

CYTX: 0.48 (-0.01)

Cytori Expects New Japan Laws to Boost Adoption of Cytori Cell Therapy
Business Wire - Thu Dec 04, 7:01AM CST
Cytori Therapeutics, Inc. (NASDAQ: CYTX) today confirmed that two Japanese regenerative medicine laws, which went into effect on November 25, 2014, remove regulatory uncertainties and provide a clear path for the Company to commercialize and market Cytori Cell Therapy(TM) and its Celution(R) System under the Company's existing and planned regulatory approvals.
CYTX: 0.48 (-0.01)

Eight Companies Webcast Live to Investors, December 4th at VirtualInvestorConferences.com
CNW Group - Tue Dec 02, 7:29AM CST
CEOs and top executives to take questions in real-time during formal roadshow presentations as well as meet and "chat" in virtual trade booths
SMLR: 2.06 (-0.08), ONVO: 6.84 (+0.03), CYTX: 0.48 (-0.01), IAG: 2.41 (+0.06)

Global Regenerative Medicines Market 2014-2020 - Technology, Application and Geography Analysis of the $67 Billion Industry
M2 - Wed Nov 26, 5:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/bx37gm/global) has announced the addition of the "Global Regenerative Medicines Market 2014-2020 - Technology, Application and Geography Analysis of the $67 Billion Industry" report to their offering. The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells. The factors driving growth of this market include advancements in stem cell therapy, significance of nanotechnology and increasing incidences of degenerative diseases. Stem cells have unique ability of proliferation and differentiation. These cells can differentiate into any cell lineage. This distinctive characteristic of stem cells has made them of significant importance in this field. Additionally, the utilization of nano-materials in wound care, drug delivery and immunomodulation is opening growth avenues for the regenerative medicine market. However, the stringent regulations and the high cost of treatment act as hindrance for the progress of this market. The increasing focus on stem cells, their applications and the emerging economies would all contribute to the growth of this market. The developing nations are adopting technological advancements at a rapid pace, which would aid in the expansion of this market throughout the globe. KEY BENEFITS - The report provides an evaluation of drivers and restraints in this market, which would affect its growth. An assessment of opportunities is given to understand the growth avenues - The technology segment helps in understanding the present technologies used in this market - The application segment describes the availability of product based on type of diseases and discusses the ongoing studies for other disorders - The segmentation based on geography helps in analyzing advancements in regenerative medicine market throughout the globe - The projections in the report are made by analyzing the current market trends and future market potential for the period of 2013-2020 - The key strategies adopted by the market players are discussed to provide an insight on the winning approaches followed by the companies - Porter's five forces analysis is used to assess the present industrial scenario to help stakeholders in making decisive moves Scope of the Report MARKET BY TECHNOLOGY - Small molecules and Biologics - Gene therapy - Cell therapy MARKET BY APPLICATION - Dermatology - Cardiovascular - CNS - Orthopedic - Dental - Others - Autoimmune disorders - Muscle regeneration - Ocular diseases Companies Mentioned - Advanced Cell Technology - Athersys Inc. - Cytomedix - Cytori Therapeutics - Genzyme - Kinetic Concepts - Mesoblast Ltd. - NuVasive - Shire pharmaceuticals - Stem Cells For more information visit http://www.researchandmarkets.com/research/bx37gm/global
CYTX: 0.48 (-0.01), ATHX: 1.30 (-0.03)

Cytori: Why This Undervalued Cell-Therapy Biotech Is A Buy
Biotech Value Finder - at Seeking Alpha - Tue Nov 25, 8:20PM CST
Summary Cytori Therapeutics (NASDAQ: CYTX ) stock price has been down relentlessly throughout the majority of 2014, a steep decline attributable to multiple factors including the clinical enrollment hold placed on its ATHENA and ATHENA II trials,...
CYTX: 0.48 (-0.01)

Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy in Conjunction with Anterior Cruciate Ligament Repair
Business Wire - Fri Nov 21, 7:00AM CST
Cytori Therapeutics, Inc. (NASDAQ: CYTX) today reported positive results from a clinical study of Cytori Cell Therapy(TM) in anterior cruciate ligament (ACL) reconstruction of patients with ACL tears. The 6 month results from the first 20 patients with combination Cytori Cell Therapy and bone-patellar tendon-bone (BPTB) grafts were presented at the Barcelona Knee Symposium on November 20, 2014.
CYTX: 0.48 (-0.01)

Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast
PR Newswire - Thu Nov 20, 3:09PM CST
Cytori Therapeutics (NASDAQ: CYTX), today announced that President and CEO Marc Hedrick, M.D. will present live at VirtualInvestorConferences.com on December 4, 2014.
CYTX: 0.48 (-0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 84

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 56

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 75

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 34

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 120

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 13

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 215

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 85

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading

Top 5 Most Recently Viewed Articles

Valory Resources Enhances Leadership with Major Investment

Updated Category News Views 370

Valory Resources Secures Strategic Investment Valory Resources Inc. has made headlines by securing a strategic investment worth CAD$8.5 million from notable Canadian business figures W. Brett Wilson and Russell Wilson. This investment showcases a strong endorsement of Valory's vision, particularly regarding its steelmaking coal mining projects. New Additions to the Board...

Continue Reading
Dr. Melonie Boone Revives Boone Management Group for Modern Needs

Updated Category News Views 476

Dr. Melonie Boone Unveils a New Chapter for Boone Management Group Dr. Melonie Boone, an experienced business psychologist and former COO, has announced the exciting relaunch of Boone Management Group (BMG). This management consulting firm is set to redefine the landscape of organizational health and performance through a cutting-edge, psychology-oriented approach. With a...

Continue Reading
CPSC Addresses Recent Product Recalls for Consumer Safety

Updated Category News Views 229

Understanding Recent Product Recalls The U.S. Consumer Product Safety Commission (CPSC) has take significant steps to protect consumers from unsafe products by announcing multiple recalls. These actions aim to provide vital information that can prevent potential hazards in homes across the nation. Highlighted Product Recalls Among the recalls is a concerning announcement...

Continue Reading
Iceland Treasury Unveils New Bond Series for Market

Updated Category News Views 288

Iceland Treasury Announces New Bond Series The Icelandic Treasury has made an important announcement regarding the issuance of nine new government bond series. This move is linked to the settlement of the ÍL Fund, previously known as the Housing Financing Fund. Investors and financial analysts will want to pay close attention to these developments as they can have...

Continue Reading
Hormel Foods’ Significant Contribution to Wildfire Relief Efforts

Updated Category News Views 241

Hormel Foods’ Commitment to Community Support In response to the devastations caused by wildfires, Hormel Foods Corporation (NYSE: HRL) is stepping up to lend a hand. The company has made a pledge to support disaster relief efforts as California faces ongoing challenges brought on by these fires. This initiative underscores Hormel Foods' commitment to the well-being of...

Continue Reading